secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nascent Biotech Inc. (—)
CIK:        0001622057
Form:       8-K
Filed at:   2025-01-17T23:59:59+00:00
Accession:  0001477932-25-000328
Event type: other_material
Sentiment:  negative
Materiality: 0.50
Item codes: 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Nascent Biotech director resigns; company faces OTC delinquency for late filing
-------------------------------------------------------------------------------

- Douglas Karas resigned as independent director on Jan 10, 2025 due to personal health issues.
- Company received OTC delinquency for untimely filing; will file Q3 2025 (likely Q3 2024) to maintain pink sheet status.
- Directors and officers agreed to terminate non-dilutive stock clause in employment contracts.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1622057/000147793225000328/0001477932-25-000328-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1622057/000147793225000328/nbio_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-25-000328

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer